Anna Tinker
0000-0002-1190-7746
British Columbia Cancer Agency
4 papers found
Refreshing results…
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Missing publications? Search for publications with a matching author name.